Examples of using Pledpharma in English and their translations into Swedish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Financial Information| PledPharma.
PledPharma AB. All rights reserved.
Corporate presentation| PledPharma Home.
PledPharma has chosen PCG
Share capital development| PledPharma AB Start.
PledPharma develops novel therapies for life-threatening diseases.
Additional topline results presented at MASCC| PledPharma Home.
PledPharma AB has started a clinical phase II study.
Click on the links below for two new publications on PledPharma drug development.
PledPharma receives research grant for cancer study| PledPharma Home.
Year-end report discussion with Nicklas Westerholm| PledPharma Home.
It is time for PledPharma to take the step towards becoming an independent company.
PledPharma has interviewed three doctors involved in the ongoing colorectal cancer study PLIANT.
Other current assignments: Board member of PledPharma AB(publ) and SpineMedical AB and deputy board member of LPB Sweden AB.
PledPharma announces publication of case study in a scientific journal| PledPharma Home.
PledPharma support WWF's work on preserving the conditions for the polar bear's arctic habitat.
PledPharma has currently two projects in clinical Phase II,
PledPharma receives final approval from the Ethical Committee to start clinical study| PledPharma Home.
PledPharma develops PledOx® to provide patients, undergoing cancer treatment, protection against these nerve damage.
PledPharma develops PledOx® to provide patients, undergoing cancer treatment, protection against these nerve damage. Filed under.
PledPharma receives approval to conduct a clinical phase II study in patients with Acute Myocardial Infarction| PledPharma Home.
PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference.
Our Vision PledPharma is a leading pharmaceutical company developing new
PledPharma AB develops new medicines based on Low Molecular weight Enzyme Mimetics(LowMEM)
PledPharma aims to create value for patients,
PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference Stockholm Stock Exchange: PLED.
PledPharma develops pharmaceuticals that improve treatment of people with debilitating
PledPharma AB(publ) presents additional topline results from PLIANT- a Phase IIb study with the drug candidate PledOx®- at the scientific conference MASCC(Multinational Association of Supportive Care in Cancer) in Copenhagen.
PledPharma presents new in-depth follow-up data from PLIANT study- PledOx® shown to reduce chemotherapy-induced peripheral neuropathy by 75 percent,
PledPharma AB(publ) announces that the company has filed an application for an Orphan Drug Designation(ODD) to the US FDA for the drug candidate Aladote®,
